BioCentury
ARTICLE | Clinical News

Mirna preclinical data

May 14, 2012 7:00 AM UTC

In a mouse xenograft model of DLBCL, intratumoral miR-34 reduced tumor growth by 95% vs. miRNA-treated negative controls. Tumors treated with miR-34 had significantly higher rates of apoptosis vs. miR...